Wells Fargo Comments on Teva (TEVA) Debt Downgrade

November 7, 2017 4:29 AM EST Send to a Friend
Wells Fargo maintains Market Perform on Teva Pharma (NYSE: TEVA).Analyst David Maris says TEVA has $6 billion in term loans ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login